Search for: "GE Healthcare AS" Results 1 - 20 of 239
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Nov 2023, 12:56 pm by Bill Marler
Capillary lead levels 3.5 µg/dL require confirmatory testing with a venous blood level to rule out contamination. [read post]
5 Sep 2023, 2:57 am by Katelynn Minott, CPA & CEO
Note for retirees: Gaining enrollment in France’s healthcare system can be a slow process. [read post]
19 Jul 2023, 9:06 pm by Jonan Pilet
  This year’s award winners are Arun Bhunia, Cathy Cutter, Beilei Ge, Vickie Lewandowski and David Tharp. [read post]
19 Jul 2023, 2:12 pm by lcampbell@lawbc.com
“Can be used in households, commercial, and institutional settings, such as (but not limited to): homes, professional offices, schools, cafeterias (both in healthcare or non-healthcare settings), garages, gyms, playground and play areas, and others. [read post]
24 May 2023, 12:00 am by Lawrence Solum
This inequity needs to be at the core of any climate chan ge research both at a practical and theoretical level. [read post]
13 Feb 2023, 12:27 pm by Caitlin Lentz
Our attorneys are experienced in advising healthcare businesses and pain management practices. [read post]
7 Feb 2023, 8:47 am by Tom Lamb
Here is the Global Pharma Healthcare announcement about this artificial tears eye drops recall involving EzriCare and Delsam brand name products in February 2023: "Global Pharma Healthcare Issues Voluntary Nationwide Recall of Artificial Tears Lubricant Eye Drops Due to Possible Contamination". [read post]
The healthcare sector in Brazil is one of the most important in the world in view of the size of the population (+220 million people) and the availability of a universal public healthcare system. [read post]
29 Nov 2022, 6:22 pm by Kurt R. Karst
“[B]efore increasing total opioid dosage to 50 MME/day, clinicians should pause and carefully reassess evidence of individual benefits and risks. [read post]
5 May 2022, 4:15 am by Jonathan Stroud
A new abbreviated new drug application (ANDA) Paragraph IV suit was launched—GE Healthcare challenging the three remaining patents over their ANDA application to bring a generic Lexiscan® drug to market, against brand Astellas and Gilead. [read post]